Medicines Co (NASDAQ:MDCO)

Monday’s trading has closed, but MDCO is being traded in the after-hours session. After-Hours quote »
29.11
Delayed Data
As of 3:59pm ET
 +0.345 / +1.20%
Today’s Change
19.92
Today|||52-Week Range
31.00
+5.20%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.9B

Company Description

The Medicines Co. is a pharmaceutical company, which focuses on advancing the treatment of critical care patients through the delivery of medicines to the worldwide hospital marketplace. The company has three marketed products, Angiomax, Cleviprex inject able emulsion and its ready-to-use formulation of Argatroban. Its also have a pipeline of acute and intensive care hospital products in development, including four late-stage development product candidates, cangrelor, oritavancin, MDCO-157 and IONSYS and three early stage development product candidates, MDCO-216, ALN-PCS02 and ALN-PCSsc. Medicines was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ.

Contact Information

The Medicines Co.
8 Sylvan Way
Parsippany New Jersey 07054-3801
P:(973) 290-6000
Investor Relations:
(973) 290-6097

Employees

Shareholders

Mutual fund holders62.15%
Other institutional42.97%
Individual stakeholders10.73%

Top Executives

Clive A. MeanwellChairman & Chief Executive Officer
Glenn P. SblendorioPresident, CFO, Treasurer & Director
Helmut GiersiefenChief Information & Knowledge Officer
Gregory FioreChief Medical Officer
David KallendVice President & Global Medical Director

To view my watchlist

Not a member yet?

Sign up now for a free account